Kingfisher Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-9,387
Closed -$840K 151
2018
Q3
$840K Sell
9,387
-75
-0.8% -$6.63K 0.45% 72
2018
Q2
$751K Sell
9,462
-764
-7% -$63.4K 0.48% 75
2018
Q1
$912K Buy
10,226
+163
+2% +$15.6K 0.58% 67
2017
Q4
$1.05M Buy
10,063
+192
+2% +$21.7K 0.67% 63
2017
Q3
$1.44M Sell
9,871
-323
-3% -$44K 0.95% 42
2017
Q2
$1.32M Buy
10,194
+344
+3% +$42.1K 0.9% 45
2017
Q1
$1.23M Sell
9,850
-2,191
-18% -$262K 0.88% 48
2016
Q4
$1.39M Sell
12,041
-1,125
-9% -$125K 1.05% 36
2016
Q3
$1.38M Buy
+13,166
New +$1.42M 0.96% 47
2014
Q4
Sell
-17,031
Closed -$1.61M 162
2014
Q3
$1.61M Sell
17,031
-63
-0.4% -$5.68K 0.86% 42
2014
Q2
$1.47M Buy
17,094
+556
+3% +$42.3K 0.76% 55
2014
Q1
$1.15M Buy
+16,538
New +$1.31M 0.61% 78

Other funds holding CELG

Kingfisher Capital's CELG Position: Q4 2018 in Review

Kingfisher Capital sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 9,387 shares — an estimated $840K sold.

Kingfisher Capital first reported a position in CELG in Q1 2014 and held it in 12 quarters. The position peaked at $1.61M in Q3 2014. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Kingfisher Capital reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Kingfisher Capital sold 9,387 Celgene Corp shares in Q4 2018, an estimated $840K.
  • Kingfisher Capital first reported a position in Celgene Corp in Q1 2014 and held it in 12 quarters.
  • Kingfisher Capital's Celgene Corp position peaked at $1.61M in Q3 2014.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Kingfisher Capital's 13F filing for Q4 2018, filed 13 Feb 2019.